Frontier Biotechnologies Statistics

Total Valuation

SHA:688221 has a market cap or net worth of CNY 7.14 billion. The enterprise value is 6.82 billion.

Market Cap	7.14B
Enterprise Value	6.82B

Important Dates

The next confirmed earnings date is Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688221 has 374.58 million shares outstanding. The number of shares has increased by 0.26% in one year.

Current Share Class	374.58M
Shares Outstanding	374.58M
Shares Change (YoY)	+0.26%
Shares Change (QoQ)	+3.96%
Owned by Insiders (%)	16.08%
Owned by Institutions (%)	6.02%
Float	211.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	792.86
PS Ratio	49.67
PB Ratio	7.27
P/TBV Ratio	8.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-26.05
EV / Sales	47.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.66% and return on invested capital (ROIC) is -11.25%.

Return on Equity (ROE)	-24.66%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-11.25%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	9.67%
Revenue Per Employee	475,724
Profits Per Employee	-866,614
Employee Count	524
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +108.48% in the last 52 weeks. The beta is 1.08, so SHA:688221's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+108.48%
50-Day Moving Average	22.67
200-Day Moving Average	17.66
Relative Strength Index (RSI)	44.97
Average Volume (20 Days)	13,801,017

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688221 had revenue of CNY 143.67 million and -261.72 million in losses. Loss per share was -0.70.

Revenue	143.67M
Gross Profit	143.67M
Operating Income	-261.39M
Pretax Income	-261.72M
Net Income	-261.72M
EBITDA	-240.76M
EBIT	-261.39M
Loss Per Share	-0.70

Full Income Statement

Balance Sheet

The company has 692.14 million in cash and 374.34 million in debt, with a net cash position of 317.80 million or 0.85 per share.

Cash & Cash Equivalents	692.14M
Total Debt	374.34M
Net Cash	317.80M
Net Cash Per Share	0.85
Equity (Book Value)	981.52M
Book Value Per Share	2.62
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -181.94% and -182.17%.

Gross Margin	100.00%
Operating Margin	-181.94%
Pretax Margin	-182.17%
Profit Margin	-182.17%
EBITDA Margin	-167.58%
EBIT Margin	-181.94%
FCF Margin	n/a

Dividends & Yields

SHA:688221 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.26%
Shareholder Yield	-0.26%
Earnings Yield	-3.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1